WWOX hypomorphic mice display a higher incidence of B‐cell lymphomas and develop testicular atrophy

WWOX is a putative tumor suppressor gene encoded within common chromosomal fragile site region FRA16D, in chromosome band 16q23. Multiple studies have demonstrated that WWOX expression is often reduced or lost in various tumor types. WWOX tumor suppressor activity was suggested by re‐expressing WWOX in breast, ovarian, and lung tumor cell lines leading to tumor growth inhibition in vivo. To determine whether loss of Wwox gene expression has a role in tumorigenesis, we generated a mouse strain containing a Wwox gene mutated by a gene‐trap vector. Homozygous Wwox gene‐trap mice ( Wwox gt/gt ) had no detectable Wwox protein in most tissues examined, although, a low level could be detected in a minority of tissues. Because of these observations, we concluded that these mice are Wwox hypomorphs. Remarkably, Wwox hypomorphic mice are viable in contrast to the recently reported postnatal lethality of Wwox knockout mice. Testes from Wwox gt/gt males had high numbers of atrophic seminiferous tubules and reduced fertility when compared with wild‐type counterparts. We observed that the Wwox gt/gt mice had a significantly shorter lifespan, and female hypomorphs had a higher incidence of spontaneous B‐cell lymphomas. In conclusion, we describe a novel Wwox hypomorphic mouse model that overcomes postnatal lethality that was recently observed in Wwox knockout mice. Therefore, tumorigenesis studies using this model more closely recapitulates the loss of WWOX expression observed in human cancers. Importantly, our observation that Wwox hypomorphs had an increased incidence of B‐cell lymphomas supports a role of Wwox as a tumor suppressor. © 2007 Wiley‐Liss, Inc.